Developmental influences on speech-motor equivalence: some implications for articulatory disordered children

The peak amplitude of EMG activity was measured from the orbicularis oris superior (OOS), orbicularis oris inferior (OOI) and masseter muscles for 3 normal 4-yr.-old children and compared to past data gathered on a group of articulatory disordered children, normal children, and adults. The 4-yr.-olds evidenced greater average peak EMG activity than the other groups, suggesting that speech-sound production becomes more efficient with maturation. Also, levels of variability obtained for the younger children were considerably smaller than for the normal speakers across the three muscles, showing that motor equivalence changes with age whereby the flexibility in the control of articulators increases. The coefficient of variation for the OOI muscle for the disordered children, however, was similar to that for the 4-yr.-olds, while the corresponding data for the other two muscles paralleled those for normal ones. These findings were interpreted as reflecting a delay in the development of speech-motor equivalence that affects certain muscles while sparing others.     

Decisional processing in paranoid and non-paranoid schizophrenics

40 schizophrenic subjects, divided into paranoid/non-paranoid categories and 14 normal controls were presented a task which involved making "same-different" judgments during random presentations of a series of visual comparison stimuli with a standard which represented the midpoint of the stimulus continuum. Using Sternberg's Choice RT paradigm for studying the locus of cognitive deficit, difficulty at the response-selection stage was manipulated while holding other stages constant. It was predicted that paranoids would have shorter RTs at easy decision points and longer RTs at difficult decision points relative to non-paranoids. The directions of the differences were as predicted but did not attain statistical significance. Both schizophrenic groups, compared to normals, made significantly fewer "same" responses on those trials where the comparison and standard were most similar.